Home » News » India » Cadila to End Late-stage Trials of Potential Covid-19 Vaccine in March
1-MIN READ

Cadila to End Late-stage Trials of Potential Covid-19 Vaccine in March

Representative Image.

Representative Image.

Cadila's vaccine candidate, dubbed ZyCov-D, is one of dozens being developed around the world to fight the coronavirus.

India's Zydus Cadila plans to complete late-stage trials for its potential coronavirus vaccine in March 2021 and could produce up to 100 million doses a year if trials are successful, Chairman Pankaj Patel told Reuters.

Cadila's vaccine candidate, dubbed ZyCov-D, is one of dozens being developed around the world to fight the coronavirus.